US Clinical Trials Expand

MCRI to expand the number of clinical centers for the On-X valve FDA study

AUSTIN, TX — December 01, 1998 – The U.S. Food and Drug Administration granted unconditional Investigational Device Exemption (IDE) that allows MCRI to expand the number of clinical centers for the On-X valve FDA study in the United States. This IDE supercedes the conditional IDE granted in Spectember, 1997.